Definitive Contract 75N91018C00027
Award Date
9/18/18
Potential Completion Date
4/17/21
Potential Value
$350K
Federal Agency
National Cancer Institute
Awardee
Sibtech, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Brookfield, CT 06804, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
<p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a civilian agency, to Sibtech, Inc., a for-profit manufacturer, in the amount of $2,256,052.35. The contract is for the development of systemic radionuclide therapy targeted to VEGF receptors in tumor vasculature. The contract has a firm fixed price pricing type and an ultimate completion date of October 31, 2021. This contract is a set-aside for small businesses.</p>
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Pact & Health LLC, a for-profit limited liability company located in Branford, Connecticut. The contract, awarded on September 11, 2019, has a potential value of $299,799.00 and is for the development of a versatile radiation-triggered phosphor platform for localized anti-cancer therapy. The contract is a...
This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
This is a $355,000.00 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to Petri Bio Inc., a small business, under the Small Business Innovation Research (SBIR) Phase I program. The contract is for the development of engineered microbial therapeutics for the treatment of heritable forms of glioma, a type of brain cancer. The work is focused on demonstrating technical feasibility and proof-of-concept for this therapeutic technology....
This is a $299,640.99 Firm Fixed Price contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Cellsight Technologies, Inc. The contract is for research and development services related to a noninvasive PET imaging strategy for longitudinal monitoring of the tumor microenvironment, under the Small Business Innovation Research (SBIR) program. The contract was set aside for small business participation. Cellsight Technologies, Inc....
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
This is a $289,828.00 SBIR Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Nicolalde R&D LLC, a minority-owned, self-certified small disadvantaged business. The contract is a firm fixed-price definitive contract with a completion date of November 30, 2021. The SBIR (Small Business Innovation Research) Program Phase I award indicates this contract is for early-stage research and development activities. As a...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (DHHS), to Theranano LLC, a small disadvantaged, woman-owned business. The $300,000 fixed-price contract is for research on the sustained delivery of PARP inhibitors for cancer chemoprevention. This SBIR contract was issued under the DHHS/NIH/CDC SBIR Contract Solicitation PHS 2018-1, which sought proposals from small...